利用半连续性微型混合技术,在商业产量条件下强化药粉混合工艺

IF 5.2 2区 医学 Q1 PHARMACOLOGY & PHARMACY
Maarten Jaspers , Florian Tegel , Timo P. Roelofs , Fabian Starsich , Yunfei Li Song , Bernhard Meir , Richard Elkes , Bastiaan H.J. Dickhoff
{"title":"利用半连续性微型混合技术,在商业产量条件下强化药粉混合工艺","authors":"Maarten Jaspers ,&nbsp;Florian Tegel ,&nbsp;Timo P. Roelofs ,&nbsp;Fabian Starsich ,&nbsp;Yunfei Li Song ,&nbsp;Bernhard Meir ,&nbsp;Richard Elkes ,&nbsp;Bastiaan H.J. Dickhoff","doi":"10.1016/j.ijpx.2024.100264","DOIUrl":null,"url":null,"abstract":"<div><p>Process intensification involves the miniaturization of equipment while retaining process throughput and performance. The pharmaceutical industry can benefit from this approach especially during drug product development, where the availability of active pharmaceutical ingredients (API) is often limited. It reduces the need for process scale up, as equipment used during product development and commercial production is identical. However, applications of process intensification for processing pharmaceutical powders are limited so far. Here we show that semi-continuous mini-blending can be utilized for process intensification of blending of API and excipients. Uniform blending at commercially relevant throughputs was achieved through mini-blends with a volume of less than ten liters. Our results demonstrate that blending speed, cycle time and blender fill level can be optimized without compromising blending performance. Acceptable blend uniformity is obtained over a broad range of operating parameters, by choosing the right excipients. The optimized throughput of the mini-blending process is in line with the desired throughput of a commercial Continuous Direct Compression (CDC) process.</p></div>","PeriodicalId":14280,"journal":{"name":"International Journal of Pharmaceutics: X","volume":"8 ","pages":"Article 100264"},"PeriodicalIF":5.2000,"publicationDate":"2024-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590156724000367/pdfft?md5=89fff000d4ba805a50dd10ee04fa86a4&pid=1-s2.0-S2590156724000367-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Process intensification of pharmaceutical powder blending at commercial throughputs by utilizing semi-continuous mini-blending\",\"authors\":\"Maarten Jaspers ,&nbsp;Florian Tegel ,&nbsp;Timo P. Roelofs ,&nbsp;Fabian Starsich ,&nbsp;Yunfei Li Song ,&nbsp;Bernhard Meir ,&nbsp;Richard Elkes ,&nbsp;Bastiaan H.J. Dickhoff\",\"doi\":\"10.1016/j.ijpx.2024.100264\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Process intensification involves the miniaturization of equipment while retaining process throughput and performance. The pharmaceutical industry can benefit from this approach especially during drug product development, where the availability of active pharmaceutical ingredients (API) is often limited. It reduces the need for process scale up, as equipment used during product development and commercial production is identical. However, applications of process intensification for processing pharmaceutical powders are limited so far. Here we show that semi-continuous mini-blending can be utilized for process intensification of blending of API and excipients. Uniform blending at commercially relevant throughputs was achieved through mini-blends with a volume of less than ten liters. Our results demonstrate that blending speed, cycle time and blender fill level can be optimized without compromising blending performance. Acceptable blend uniformity is obtained over a broad range of operating parameters, by choosing the right excipients. The optimized throughput of the mini-blending process is in line with the desired throughput of a commercial Continuous Direct Compression (CDC) process.</p></div>\",\"PeriodicalId\":14280,\"journal\":{\"name\":\"International Journal of Pharmaceutics: X\",\"volume\":\"8 \",\"pages\":\"Article 100264\"},\"PeriodicalIF\":5.2000,\"publicationDate\":\"2024-06-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2590156724000367/pdfft?md5=89fff000d4ba805a50dd10ee04fa86a4&pid=1-s2.0-S2590156724000367-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Pharmaceutics: X\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2590156724000367\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Pharmaceutics: X","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590156724000367","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

工艺强化包括在保持工艺吞吐量和性能的同时,实现设备的微型化。制药业可以从这种方法中获益,尤其是在药物产品开发过程中,因为药物活性成分(API)的供应往往是有限的。由于产品开发和商业生产过程中使用的设备完全相同,因此可以减少对工艺放大的需求。然而,迄今为止,工艺强化在加工药粉方面的应用还很有限。在这里,我们展示了半连续式微型混合工艺可用于原料药和辅料混合的工艺强化。通过体积小于 10 升的微型混合器,实现了具有商业相关吞吐量的均匀混合。我们的研究结果表明,可以在不影响混合性能的情况下优化混合速度、周期时间和混合器填充水平。通过选择合适的辅料,可在广泛的操作参数范围内获得可接受的混合均匀度。小型混合工艺的优化产量与商用连续直接压缩(CDC)工艺的理想产量一致。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Process intensification of pharmaceutical powder blending at commercial throughputs by utilizing semi-continuous mini-blending

Process intensification of pharmaceutical powder blending at commercial throughputs by utilizing semi-continuous mini-blending

Process intensification involves the miniaturization of equipment while retaining process throughput and performance. The pharmaceutical industry can benefit from this approach especially during drug product development, where the availability of active pharmaceutical ingredients (API) is often limited. It reduces the need for process scale up, as equipment used during product development and commercial production is identical. However, applications of process intensification for processing pharmaceutical powders are limited so far. Here we show that semi-continuous mini-blending can be utilized for process intensification of blending of API and excipients. Uniform blending at commercially relevant throughputs was achieved through mini-blends with a volume of less than ten liters. Our results demonstrate that blending speed, cycle time and blender fill level can be optimized without compromising blending performance. Acceptable blend uniformity is obtained over a broad range of operating parameters, by choosing the right excipients. The optimized throughput of the mini-blending process is in line with the desired throughput of a commercial Continuous Direct Compression (CDC) process.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
International Journal of Pharmaceutics: X
International Journal of Pharmaceutics: X Pharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science
CiteScore
6.60
自引率
0.00%
发文量
32
审稿时长
24 days
期刊介绍: International Journal of Pharmaceutics: X offers authors with high-quality research who want to publish in a gold open access journal the opportunity to make their work immediately, permanently, and freely accessible. International Journal of Pharmaceutics: X authors will pay an article publishing charge (APC), have a choice of license options, and retain copyright. Please check the APC here. The journal is indexed in SCOPUS, PUBMED, PMC and DOAJ. The International Journal of Pharmaceutics is the second most cited journal in the "Pharmacy & Pharmacology" category out of 358 journals, being the true home for pharmaceutical scientists concerned with the physical, chemical and biological properties of devices and delivery systems for drugs, vaccines and biologicals, including their design, manufacture and evaluation. This includes evaluation of the properties of drugs, excipients such as surfactants and polymers and novel materials. The journal has special sections on pharmaceutical nanotechnology and personalized medicines, and publishes research papers, reviews, commentaries and letters to the editor as well as special issues.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信